Triad Therapeutics, Inc. Release: Aperture Health, Inc. Seeks to Become a Leading Partner for Accountable Care Organizations
6/7/2012 11:06:30 AM
More...
|
Triad Therapeutics, Inc. Release: Aperture Health, Inc. Announces Certification to Provide Medication Therapy Management in the Home
4/24/2012 9:52:35 AM
More...
|
Triad Therapeutics, Inc. Release: Aperture Health, Inc. Enters Into Discussions to Form a Joint Venture to Offer Its' Services to the Pet Med Marketplace
2/1/2012 10:42:57 AM
More...
|
Arisaph Pharmaceuticals Reports On Promising Results Presented At American Heart Association: Novel Apo A-I Mimetic Peptide Significantly Inhibits Atherosclerosis In Preclinical Animal Study
11/14/2005 1:33:25 PM
More...
|
Triad Therapeutics, Inc. Reports Sale Of p38 Kinase Inflammation Program To Novartis Pharma AG (NVS); $66 Million
10/19/2005 5:12:23 PM
More...
|